These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20822110)

  • 21. Design, synthesis and biological evaluation of novel pyrrolidone-based derivatives as potent p53-MDM2 inhibitors.
    Si D; Luo H; Zhang X; Yang K; Wen H; Li W; Liu J
    Bioorg Chem; 2021 Oct; 115():105268. PubMed ID: 34426149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural polypeptide-based supramolecular nanogels for stable noncovalent encapsulation.
    Kim K; Bae B; Kang YJ; Nam JM; Kang S; Ryu JH
    Biomacromolecules; 2013 Oct; 14(10):3515-22. PubMed ID: 23962280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-Based Programming of Supramolecular Assemblies in Living Cells for Selective Cancer Cell Inhibition.
    Hu L; Li Y; Lin X; Huo Y; Zhang H; Wang H
    Angew Chem Int Ed Engl; 2021 Sep; 60(40):21807-21816. PubMed ID: 34189812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyl Group Difference between Anthraquinone Derivatives Regulate Different Cell Death Pathways via Nucleo-Cytoplasmic Shuttling of p53.
    Kamil M; Haque E; Mir SS; Irfan S; Hasan A; Sheikh S; Alam S; Ansari KM; Nazir A
    Anticancer Agents Med Chem; 2019; 19(2):184-193. PubMed ID: 30370860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of novel antitumor spirotetrahydrothiopyran-oxindole derivatives as potent p53-MDM2 inhibitors.
    Ji C; Wang S; Chen S; He S; Jiang Y; Miao Z; Li J; Sheng C
    Bioorg Med Chem; 2017 Oct; 25(20):5268-5277. PubMed ID: 28797774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise pH-sensitive and biodegradable polypeptide hybrid micelles for enhanced cellular internalization and efficient nuclear drug delivery.
    Qu J; Peng S; Wang R; Yang ST; Zhou QH; Lin J
    Colloids Surf B Biointerfaces; 2019 Sep; 181():315-324. PubMed ID: 31154142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comb-like amphiphilic copolymers bearing acetal-functionalized backbones with the ability of acid-triggered hydrophobic-to-hydrophilic transition as effective nanocarriers for intracellular release of curcumin.
    Zhao J; Wang H; Liu J; Deng L; Liu J; Dong A; Zhang J
    Biomacromolecules; 2013 Nov; 14(11):3973-84. PubMed ID: 24107101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.
    Atatreh N; Ghattas MA; Bardaweel SK; Rawashdeh SA; Sorkhy MA
    Drug Des Devel Ther; 2018; 12():3741-3752. PubMed ID: 30464405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lanthanide-doped nanoparticles conjugated with an anti-CD33 antibody and a p53-activating peptide for acute myeloid leukemia therapy.
    Niu F; Yan J; Ma B; Li S; Shao Y; He P; Zhang W; He W; Ma PX; Lu W
    Biomaterials; 2018 Jun; 167():132-142. PubMed ID: 29571049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amphiphilic CCK peptides assembled in supramolecular aggregates: structural investigations and in vitro studies.
    Accardo A; Morisco A; Palladino P; Palumbo R; Tesauro D; Morelli G
    Mol Biosyst; 2011 Mar; 7(3):862-70. PubMed ID: 21157624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of AM-7209, a potent and selective 4-amidobenzoic acid inhibitor of the MDM2-p53 interaction.
    Rew Y; Sun D; Yan X; Beck HP; Canon J; Chen A; Duquette J; Eksterowicz J; Fox BM; Fu J; Gonzalez AZ; Houze J; Huang X; Jiang M; Jin L; Li Y; Li Z; Ling Y; Lo MC; Long AM; McGee LR; McIntosh J; Oliner JD; Osgood T; Saiki AY; Shaffer P; Wang YC; Wortman S; Yakowec P; Ye Q; Yu D; Zhao X; Zhou J; Medina JC; Olson SH
    J Med Chem; 2014 Dec; 57(24):10499-511. PubMed ID: 25384157
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Kazemi M; Emami J; Hasanzadeh F; Minaiyan M; Mirian M; Lavasanifar A; Mokhtari M
    Recent Pat Anticancer Drug Discov; 2020; 15(4):341-359. PubMed ID: 33023456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-peptide inhibitors of the p53-MDM2 interaction for targeted molecular therapy of malignant neoplasms.
    Liu M; Li C; Pazgier M; Li C; Mao Y; Lv Y; Gu B; Wei G; Yuan W; Zhan C; Lu WY; Lu W
    Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14321-6. PubMed ID: 20660730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone H2A-peptide-hybrided upconversion mesoporous silica nanoparticles for bortezomib/p53 delivery and apoptosis induction.
    Rong J; Li P; Ge Y; Chen H; Wu J; Zhang R; Lao J; Lou D; Zhang Y
    Colloids Surf B Biointerfaces; 2020 Feb; 186():110674. PubMed ID: 31855686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors.
    Hu C; Li X; Wang W; Zhang L; Tao L; Dong X; Sheng R; Yang B; Hu Y
    Bioorg Med Chem; 2011 Sep; 19(18):5454-61. PubMed ID: 21855354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNYL peptide functional chitosan-g-stearate conjugate micelles for tumor specific targeting.
    Chen FY; Yan JJ; Yi HX; Hu FQ; Du YZ; Yuan H; You J; Zhao MD
    Int J Nanomedicine; 2014; 9():4597-608. PubMed ID: 25298734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biofunctional supramolecular hydrogels fabricated from a short self-assembling peptide modified with bioactive sequences for the 3D culture of breast cancer MCF-7 cells.
    Chia JY; Miki T; Mihara H; Tsutsumi H
    Bioorg Med Chem; 2021 Sep; 46():116345. PubMed ID: 34416510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporation of camptothecin into reduction-degradable supramolecular micelles for enhancing its stability.
    Luo P; Luo Y; Huang J; Lu W; Luo D; Yu J; Liu S
    Colloids Surf B Biointerfaces; 2013 Sep; 109():167-75. PubMed ID: 23643912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supramolecularly self-assembled nano-twin drug for reversing multidrug resistance.
    Wu C; Xu L; Shi L; Gao X; Li J; Zhu X; Zhang C
    Biomater Sci; 2018 Jul; 6(8):2261-2269. PubMed ID: 29999073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.